Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023
Nathaniel M Lewis,Yuwei Zhu,Ithan D Peltan,Manjusha Gaglani,Tresa McNeal,Shekhar Ghamande,Jay S Steingrub,Nathan I Shapiro,Abhijit Duggal,William S Bender,Leyla Taghizadeh,Samuel M Brown,David N Hager,Michelle N Gong,Amira Mohamed,Matthew C Exline,Akram Khan,Jennifer G Wilson,Nida Qadir,Steven Y Chang,Adit A Ginde,Nicholas M Mohr,Christopher Mallow,Adam S Lauring,Nicholas J Johnson,Kevin W Gibbs,Jennie H Kwon,Cristie Columbus,Robert L Gottlieb,Catherine Raver,Ivana A Vaughn,Mayur Ramesh,Cassandra Johnson,Lois Lamerato,Basmah Safdar,Jonathan D Casey,Todd W Rice,Natasha Halasa,James D Chappell,Carlos G Grijalva,H Keipp Talbot,Adrienne Baughman,Kelsey N Womack,Sydney A Swan,Elizabeth Harker,Ashley Price,Jennifer DeCuir,Diya Surie,Sascha Ellington,Wesley H Self,Investigating Respiratory Viruses in the Acutely Ill (IVY) Network,Nicole Calhoun,Kempapura Murthy,Joselyn Cravens,Judy Herrick,Amanda McKillop,Eric Hoffman,Ashley Graves,Martha Zayed,Michael Smith,Baylor Scott,White Health,Tammy Fisher,Mariana Hurutado-Rodriguez,Taryn Kruse,Symone Dunkley,Gabriela Perez,Ashley Bychkowski,Therissa Grefsrud,Jay Steingrub,Lori-Ann Kozikowski,Lesley De Souza,Scott Ouellette,Michael Bolstad,Brianna Coviello,Robert Ciottone,Arnaldo Devilla,Ana Grafals,Conor Higgins,Carlo Ottanelli,Kimberly Redman,Douglas Scaffidi,Alexander Weingart,Meredith McMorrow,Nathaniel Lewis,Omar Mehkri,Megan Mitchell,Zachary Griffith,Connery Brennan,Kiran Ashok,Bryan Poynter,Laurence Busse,Caitlin Ten Lohuis,Nicholas Stanley,Sophia Zhang,Matthew E Prekker,Anne E P Frosch,Audrey Hendrickson,Stephen Douglas,Kowsar Hurreh,Ithan Peltan,Cassie Smith,Hunter Marshall,Harith Ali,Minh Phan,Michelle Gong,Rahul Nair,Jen-Ting Tina Chen,Matthew Exline,Sarah Karow,Maryiam Khan,Madison So,Connor Snyder,Gabrielle Swoope,David Smith,Brooke Lee,Amanie Rasul,Manisha Pathak,Zachery Lewald,Reece Wilson,José Peña,Genesis Briceno,Cassandra Ahmed,Jesus Martinez,Edvinas Pocius,Minn Oh,Jessica Hyde,Sherie Gause,Alexandra June Gordon,Cynthia Perez,Lily Lau,Ismail Hakki Bekiroglu,Cody Tran,Trevor Frankel,Omai Garner,Sukantha Chandrasekaran,Adit Ginde,David Douin,Amanda Martinez,David Huynh,Aimee Steinwand,Amy Sullivan,Cori Withers,Nicholas Mohr,Anne Zepeski,Paul Nassar,Shannon Landers,Karin Nielsen,Noble Briggs,Cathy Fairfield,Alex Peebles,Chris Mallow,Carolina Rivas,Emily Martin,Arnold Monto,Adam Lauring,E J McSpadden,Rachel Truscon,Anne Kaniclides,Lara Thomas,Ramsay Bielak,Weronika Damek Valvano,Rebecca Fong,William J Fitzsimmons,Christopher N Blair,Julie Gilbert,Leigh Papalambros,Ankur Holz,Nicholas Johnson,Vasisht Srinivasan,Christine D Crider,Kyle A Steinbock,Thomas C Paulsen,Layla A Anderson,Carlos Grijalva,Ian Jones,James Chappell,Kelsey Womack,Jillian Rhoads,Christy Kampe,Jakea Johnson,Sydney Swan,Todd Rice,Jonathan Casey,William B Stubblefield,Laura L Short,Lauren J Ezzell,Margaret E Whitsett,Rendie E McHenry,Samarian J Hargrave,Marcia Blair,Jennifer L Luther,Claudia Guevara Pulido,Bryan P M Peterson,D Clark Files,Kevin Gibbs,Leigha Landreth,Madeline Hicks,Lisa Parks,Jennie Kwon,Bijal Parikh,David McDonald,Carleigh Samuels,Lucy Vogt,Caroline O'Neil,Alyssa Valencia,Tiffany Hink,Mariana H Hurutado-Rodriguez,Gabriela Cantu Perez,Kim Beney,Rachna Jayaprakash,Sindhuja Koneru,Jean Ashley Lava,Zina Pinderi,Melissa Resk,Anirudh Goyal,Lauren DeLamielleure,Michael Kosover,Carolyn Brokowski
DOI: https://doi.org/10.1093/cid/ciad677
2024-04-10
Abstract:Background: Influenza circulation during the 2022-2023 season in the United States largely returned to pre-coronavirus disease 2019 (COVID-19)-pandemic patterns and levels. Influenza A(H3N2) viruses were detected most frequently this season, predominately clade 3C.2a1b.2a, a close antigenic match to the vaccine strain. Methods: To understand effectiveness of the 2022-2023 influenza vaccine against influenza-associated hospitalization, organ failure, and death, a multicenter sentinel surveillance network in the United States prospectively enrolled adults hospitalized with acute respiratory illness between 1 October 2022, and 28 February 2023. Using the test-negative design, vaccine effectiveness (VE) estimates against influenza-associated hospitalization, organ failures, and death were measured by comparing the odds of current-season influenza vaccination in influenza-positive case-patients and influenza-negative, SARS-CoV-2-negative control-patients. Results: A total of 3707 patients, including 714 influenza cases (33% vaccinated) and 2993 influenza- and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-negative controls (49% vaccinated) were analyzed. VE against influenza-associated hospitalization was 37% (95% confidence interval [CI]: 27%-46%) and varied by age (18-64 years: 47% [30%-60%]; ≥65 years: 28% [10%-43%]), and virus (A[H3N2]: 29% [6%-46%], A[H1N1]: 47% [23%-64%]). VE against more severe influenza-associated outcomes included: 41% (29%-50%) against influenza with hypoxemia treated with supplemental oxygen; 65% (56%-72%) against influenza with respiratory, cardiovascular, or renal failure treated with organ support; and 66% (40%-81%) against influenza with respiratory failure treated with invasive mechanical ventilation. Conclusions: During an early 2022-2023 influenza season with a well-matched influenza vaccine, vaccination was associated with reduced risk of influenza-associated hospitalization and organ failure.